National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
Carcinoma of Unknown Primary Treatment (PDQ®)     
Last Modified: 09/01/2009
Health Professional Version
Changes to This Summary (09/01/2009)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Cellular Classification 1

Added text 2 on gene expression profiling as a diagnostic test (cited Horlings et al. as reference 6).

Added text 3 on the use of molecular profiling to identify tissue of origin (cited Varadhachary et al. as reference 12).

Newly Diagnosed Carcinoma of Unknown Primary 4

Added text 5 to state that intensity-modulated radiation therapy may have less short- and long-term toxicity than conventional radiation therapy in terms of xerostomia, acute dysphagia, and skin fibrosis (cited Madani et al. as reference 5).



Table of Links

1http://www.cancer.gov/cancertopics/pdq/treatment/unknownprimary/HealthProfessio
nal/10.cdr#Section_10
2http://www.cancer.gov/cancertopics/pdq/treatment/unknownprimary/HealthProfessio
nal/72.cdr#Section_72
3http://www.cancer.gov/cancertopics/pdq/treatment/unknownprimary/HealthProfessio
nal/109.cdr#Section_109
4http://www.cancer.gov/cancertopics/pdq/treatment/unknownprimary/HealthProfessio
nal/43.cdr#Section_43
5http://www.cancer.gov/cancertopics/pdq/treatment/unknownprimary/HealthProfessio
nal/47.cdr#Section_47